nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.221	1	CrCtD
Nortriptyline—CHRM3—epilepsy syndrome	0.0318	0.215	CbGaD
Nortriptyline—panic disorder—Diazepam—epilepsy syndrome	0.0311	0.157	CpDpCtD
Nortriptyline—CHRM1—epilepsy syndrome	0.0297	0.201	CbGaD
Nortriptyline—multiple sclerosis—Diazepam—epilepsy syndrome	0.0265	0.134	CpDpCtD
Nortriptyline—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0265	0.134	CpDpCtD
Nortriptyline—CHRM2—epilepsy syndrome	0.0242	0.164	CbGaD
Nortriptyline—endogenous depression—Valproic Acid—epilepsy syndrome	0.0232	0.117	CpDpCtD
Nortriptyline—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0225	0.114	CpDpCtD
Nortriptyline—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0201	0.102	CpDpCtD
Nortriptyline—panic disorder—Clonazepam—epilepsy syndrome	0.0188	0.0953	CpDpCtD
Nortriptyline—multiple sclerosis—Clonazepam—epilepsy syndrome	0.016	0.0812	CpDpCtD
Nortriptyline—SLC6A4—epilepsy syndrome	0.0158	0.107	CbGaD
Nortriptyline—CYP2C19—epilepsy syndrome	0.015	0.101	CbGaD
Nortriptyline—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0129	0.0654	CpDpCtD
Nortriptyline—HTR2A—epilepsy syndrome	0.0121	0.0819	CbGaD
Nortriptyline—Epinastine—Carbamazepine—epilepsy syndrome	0.0119	0.0692	CrCrCtD
Nortriptyline—CYP2D6—epilepsy syndrome	0.0111	0.0749	CbGaD
Nortriptyline—Epinastine—Oxcarbazepine—epilepsy syndrome	0.011	0.0637	CrCrCtD
Nortriptyline—Protriptyline—Carbamazepine—epilepsy syndrome	0.0104	0.0605	CrCrCtD
Nortriptyline—Indecainide—Oxcarbazepine—epilepsy syndrome	0.00906	0.0525	CrCrCtD
Nortriptyline—Phenindione—Fosphenytoin—epilepsy syndrome	0.00892	0.0518	CrCrCtD
Nortriptyline—Phenindamine—Oxcarbazepine—epilepsy syndrome	0.00857	0.0497	CrCrCtD
Nortriptyline—ALB—epilepsy syndrome	0.0083	0.0561	CbGaD
Nortriptyline—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.00804	0.0466	CrCrCtD
Nortriptyline—Mianserin—Oxcarbazepine—epilepsy syndrome	0.00741	0.043	CrCrCtD
Nortriptyline—Phenindione—Phenytoin—epilepsy syndrome	0.00612	0.0355	CrCrCtD
Nortriptyline—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.00581	0.0337	CrCrCtD
Nortriptyline—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.00581	0.0337	CrCrCtD
Nortriptyline—Doxepin—Oxcarbazepine—epilepsy syndrome	0.00569	0.033	CrCrCtD
Nortriptyline—Phenindione—Carbamazepine—epilepsy syndrome	0.00564	0.0328	CrCrCtD
Nortriptyline—Desipramine—Carbamazepine—epilepsy syndrome	0.00534	0.031	CrCrCtD
Nortriptyline—Phenindione—Oxcarbazepine—epilepsy syndrome	0.0052	0.0302	CrCrCtD
Nortriptyline—ALB—Oxcarbazepine—epilepsy syndrome	0.00519	0.0343	CbGbCtD
Nortriptyline—Oxcarbazepine—Clobazam—epilepsy syndrome	0.00513	0.0298	CrCrCtD
Nortriptyline—CYP2E1—Trimethadione—epilepsy syndrome	0.00499	0.033	CbGbCtD
Nortriptyline—CYP2E1—Felbamate—epilepsy syndrome	0.00499	0.033	CbGbCtD
Nortriptyline—Phenindione—Clobazam—epilepsy syndrome	0.00499	0.0289	CrCrCtD
Nortriptyline—Desipramine—Oxcarbazepine—epilepsy syndrome	0.00492	0.0286	CrCrCtD
Nortriptyline—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00479	0.0278	CrCrCtD
Nortriptyline—Oxcarbazepine—Diazepam—epilepsy syndrome	0.00477	0.0277	CrCrCtD
Nortriptyline—Trimipramine—Carbamazepine—epilepsy syndrome	0.00472	0.0274	CrCrCtD
Nortriptyline—ALB—Fosphenytoin—epilepsy syndrome	0.00454	0.03	CbGbCtD
Nortriptyline—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00435	0.0252	CrCrCtD
Nortriptyline—Imipramine—Carbamazepine—epilepsy syndrome	0.00433	0.0251	CrCrCtD
Nortriptyline—CYP2E1—Clonazepam—epilepsy syndrome	0.00424	0.028	CbGbCtD
Nortriptyline—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00417	0.0276	CbGbCtD
Nortriptyline—ALB—Clonazepam—epilepsy syndrome	0.0041	0.0271	CbGbCtD
Nortriptyline—Clomipramine—Clobazam—epilepsy syndrome	0.00408	0.0237	CrCrCtD
Nortriptyline—Chlorprothixene—Midazolam—epilepsy syndrome	0.00399	0.0232	CrCrCtD
Nortriptyline—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00399	0.0232	CrCrCtD
Nortriptyline—Clomipramine—Diazepam—epilepsy syndrome	0.00379	0.022	CrCrCtD
Nortriptyline—Chlorprothixene—Diazepam—epilepsy syndrome	0.00356	0.0206	CrCrCtD
Nortriptyline—CYP2E1—Rufinamide—epilepsy syndrome	0.00346	0.0229	CbGbCtD
Nortriptyline—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00337	0.0222	CbGbCtD
Nortriptyline—ALB—Rufinamide—epilepsy syndrome	0.00334	0.0221	CbGbCtD
Nortriptyline—PTGS1—Diazepam—epilepsy syndrome	0.00331	0.0219	CbGbCtD
Nortriptyline—CYP2C19—Trimethadione—epilepsy syndrome	0.00313	0.0207	CbGbCtD
Nortriptyline—CYP2C19—Felbamate—epilepsy syndrome	0.00313	0.0207	CbGbCtD
Nortriptyline—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00294	0.0194	CbGbCtD
Nortriptyline—ALB—Phenytoin—epilepsy syndrome	0.00292	0.0193	CbGbCtD
Nortriptyline—CYP2E1—Propofol—epilepsy syndrome	0.00282	0.0186	CbGbCtD
Nortriptyline—ALB—Propofol—epilepsy syndrome	0.00273	0.018	CbGbCtD
Nortriptyline—CYP2E1—Phenobarbital—epilepsy syndrome	0.0027	0.0178	CbGbCtD
Nortriptyline—CYP2E1—Midazolam—epilepsy syndrome	0.00266	0.0176	CbGbCtD
Nortriptyline—CYP3A5—Carbamazepine—epilepsy syndrome	0.00262	0.0173	CbGbCtD
Nortriptyline—PTGS1—Valproic Acid—epilepsy syndrome	0.00261	0.0172	CbGbCtD
Nortriptyline—CYP2C9—Trimethadione—epilepsy syndrome	0.0026	0.0172	CbGbCtD
Nortriptyline—CYP2E1—Diazepam—epilepsy syndrome	0.00256	0.0169	CbGbCtD
Nortriptyline—CYP2C19—Clobazam—epilepsy syndrome	0.00255	0.0169	CbGbCtD
Nortriptyline—ALB—Diazepam—epilepsy syndrome	0.00247	0.0163	CbGbCtD
Nortriptyline—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00245	0.0162	CbGbCtD
Nortriptyline—CYP3A5—Phenytoin—epilepsy syndrome	0.00235	0.0155	CbGbCtD
Nortriptyline—CYP2C19—Carbamazepine—epilepsy syndrome	0.00211	0.014	CbGbCtD
Nortriptyline—CYP3A5—Phenobarbital—epilepsy syndrome	0.00209	0.0138	CbGbCtD
Nortriptyline—CYP3A5—Midazolam—epilepsy syndrome	0.00207	0.0136	CbGbCtD
Nortriptyline—CYP3A5—Diazepam—epilepsy syndrome	0.00199	0.0131	CbGbCtD
Nortriptyline—CYP2C19—Primidone—epilepsy syndrome	0.00197	0.013	CbGbCtD
Nortriptyline—CYP1A2—Carbamazepine—epilepsy syndrome	0.00195	0.0129	CbGbCtD
Nortriptyline—CYP2C19—Phenytoin—epilepsy syndrome	0.0019	0.0125	CbGbCtD
Nortriptyline—CYP1A2—Primidone—epilepsy syndrome	0.00182	0.012	CbGbCtD
Nortriptyline—CYP2C19—Propofol—epilepsy syndrome	0.00177	0.0117	CbGbCtD
Nortriptyline—CYP2C9—Carbamazepine—epilepsy syndrome	0.00176	0.0116	CbGbCtD
Nortriptyline—CYP2C19—Phenobarbital—epilepsy syndrome	0.00169	0.0112	CbGbCtD
Nortriptyline—CYP2C9—Primidone—epilepsy syndrome	0.00164	0.0108	CbGbCtD
Nortriptyline—CYP1A2—Propofol—epilepsy syndrome	0.00163	0.0108	CbGbCtD
Nortriptyline—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00163	0.0107	CbGbCtD
Nortriptyline—CYP2C19—Diazepam—epilepsy syndrome	0.0016	0.0106	CbGbCtD
Nortriptyline—CYP2C9—Phenytoin—epilepsy syndrome	0.00158	0.0104	CbGbCtD
Nortriptyline—CYP3A5—Valproic Acid—epilepsy syndrome	0.00157	0.0103	CbGbCtD
Nortriptyline—CYP2C19—Zonisamide—epilepsy syndrome	0.00156	0.0103	CbGbCtD
Nortriptyline—CYP1A2—Phenobarbital—epilepsy syndrome	0.00156	0.0103	CbGbCtD
Nortriptyline—CYP3A4—Felbamate—epilepsy syndrome	0.00151	0.00999	CbGbCtD
Nortriptyline—CYP3A4—Trimethadione—epilepsy syndrome	0.00151	0.00999	CbGbCtD
Nortriptyline—CYP1A2—Diazepam—epilepsy syndrome	0.00148	0.00976	CbGbCtD
Nortriptyline—CYP2C9—Propofol—epilepsy syndrome	0.00147	0.00971	CbGbCtD
Nortriptyline—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00142	0.0094	CbGbCtD
Nortriptyline—CYP2C9—Phenobarbital—epilepsy syndrome	0.0014	0.00928	CbGbCtD
Nortriptyline—CYP2D6—Propofol—epilepsy syndrome	0.00134	0.00888	CbGbCtD
Nortriptyline—CYP2C9—Diazepam—epilepsy syndrome	0.00133	0.0088	CbGbCtD
Nortriptyline—CYP3A4—Clonazepam—epilepsy syndrome	0.00129	0.0085	CbGbCtD
Nortriptyline—CYP2C19—Valproic Acid—epilepsy syndrome	0.00126	0.00834	CbGbCtD
Nortriptyline—CYP3A4—Clobazam—epilepsy syndrome	0.00123	0.00815	CbGbCtD
Nortriptyline—CYP1A2—Valproic Acid—epilepsy syndrome	0.00116	0.0077	CbGbCtD
Nortriptyline—CYP2C19—Topiramate—epilepsy syndrome	0.00114	0.00753	CbGbCtD
Nortriptyline—CYP2C9—Valproic Acid—epilepsy syndrome	0.00105	0.00694	CbGbCtD
Nortriptyline—CYP3A4—Rufinamide—epilepsy syndrome	0.00105	0.00693	CbGbCtD
Nortriptyline—HTR2A—phrenic nerve—epilepsy syndrome	0.00104	0.059	CbGeAlD
Nortriptyline—CYP3A4—Carbamazepine—epilepsy syndrome	0.00102	0.00675	CbGbCtD
Nortriptyline—CYP3A4—Primidone—epilepsy syndrome	0.000954	0.0063	CbGbCtD
Nortriptyline—CYP3A4—Phenytoin—epilepsy syndrome	0.000916	0.00605	CbGbCtD
Nortriptyline—CYP3A4—Propofol—epilepsy syndrome	0.000855	0.00565	CbGbCtD
Nortriptyline—CYP3A4—Phenobarbital—epilepsy syndrome	0.000817	0.0054	CbGbCtD
Nortriptyline—CYP3A4—Acetazolamide—epilepsy syndrome	0.000817	0.0054	CbGbCtD
Nortriptyline—CYP3A4—Midazolam—epilepsy syndrome	0.000805	0.00532	CbGbCtD
Nortriptyline—SLC6A2—locus ceruleus—epilepsy syndrome	0.000776	0.0438	CbGeAlD
Nortriptyline—CYP3A4—Diazepam—epilepsy syndrome	0.000774	0.00512	CbGbCtD
Nortriptyline—CYP3A4—Zonisamide—epilepsy syndrome	0.000756	0.00499	CbGbCtD
Nortriptyline—CYP3A4—Valproic Acid—epilepsy syndrome	0.00061	0.00403	CbGbCtD
Nortriptyline—CYP3A4—Topiramate—epilepsy syndrome	0.000551	0.00364	CbGbCtD
Nortriptyline—HTR6—ganglion—epilepsy syndrome	0.000475	0.0268	CbGeAlD
Nortriptyline—HTR2A—locus ceruleus—epilepsy syndrome	0.000467	0.0263	CbGeAlD
Nortriptyline—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000441	0.0249	CbGeAlD
Nortriptyline—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000412	0.0233	CbGeAlD
Nortriptyline—HTR2A—cerebellar cortex—epilepsy syndrome	0.00038	0.0215	CbGeAlD
Nortriptyline—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000371	0.021	CbGeAlD
Nortriptyline—HTR2A—vagus nerve—epilepsy syndrome	0.000357	0.0202	CbGeAlD
Nortriptyline—DRD2—telencephalic ventricle—epilepsy syndrome	0.000335	0.0189	CbGeAlD
Nortriptyline—HTR2C—ganglion—epilepsy syndrome	0.000275	0.0155	CbGeAlD
Nortriptyline—HTR2A—pons—epilepsy syndrome	0.000269	0.0152	CbGeAlD
Nortriptyline—SLC6A4—ganglion—epilepsy syndrome	0.00026	0.0147	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—epilepsy syndrome	0.000248	0.014	CbGeAlD
Nortriptyline—HTR1A—ganglion—epilepsy syndrome	0.000231	0.013	CbGeAlD
Nortriptyline—SLC6A2—ganglion—epilepsy syndrome	0.000229	0.0129	CbGeAlD
Nortriptyline—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000221	0.0125	CbGeAlD
Nortriptyline—DRD2—ganglion—epilepsy syndrome	0.000209	0.0118	CbGeAlD
Nortriptyline—HTR6—forebrain—epilepsy syndrome	0.000199	0.0112	CbGeAlD
Nortriptyline—SLC6A4—hindbrain—epilepsy syndrome	0.000197	0.0111	CbGeAlD
Nortriptyline—HTR6—telencephalon—epilepsy syndrome	0.000183	0.0103	CbGeAlD
Nortriptyline—HTR1A—hindbrain—epilepsy syndrome	0.000175	0.00989	CbGeAlD
Nortriptyline—ADRA1A—hindbrain—epilepsy syndrome	0.000162	0.00912	CbGeAlD
Nortriptyline—DRD2—hindbrain—epilepsy syndrome	0.000158	0.00894	CbGeAlD
Nortriptyline—ADRA1D—forebrain—epilepsy syndrome	0.000156	0.00878	CbGeAlD
Nortriptyline—PTGS1—ganglion—epilepsy syndrome	0.000153	0.00861	CbGeAlD
Nortriptyline—ADRA1D—telencephalon—epilepsy syndrome	0.000143	0.00807	CbGeAlD
Nortriptyline—HTR2A—ganglion—epilepsy syndrome	0.000138	0.00777	CbGeAlD
Nortriptyline—CHRM4—head—epilepsy syndrome	0.000128	0.0072	CbGeAlD
Nortriptyline—CHRM4—nervous system—epilepsy syndrome	0.000121	0.00682	CbGeAlD
Nortriptyline—CHRM2—forebrain—epilepsy syndrome	0.000119	0.00674	CbGeAlD
Nortriptyline—HTR2C—brainstem—epilepsy syndrome	0.000119	0.00674	CbGeAlD
Nortriptyline—CHRM4—central nervous system—epilepsy syndrome	0.000116	0.00657	CbGeAlD
Nortriptyline—Olopatadine—S100B—epilepsy syndrome	0.000115	0.0766	CrCbGaD
Nortriptyline—HTR2C—forebrain—epilepsy syndrome	0.000115	0.0065	CbGeAlD
Nortriptyline—HTR6—head—epilepsy syndrome	0.000114	0.00644	CbGeAlD
Nortriptyline—SLC6A4—brainstem—epilepsy syndrome	0.000113	0.00638	CbGeAlD
Nortriptyline—CHRM2—telencephalon—epilepsy syndrome	0.00011	0.0062	CbGeAlD
Nortriptyline—SLC6A4—forebrain—epilepsy syndrome	0.000109	0.00616	CbGeAlD
Nortriptyline—CHRM1—forebrain—epilepsy syndrome	0.000109	0.00614	CbGeAlD
Nortriptyline—HTR6—nervous system—epilepsy syndrome	0.000108	0.00611	CbGeAlD
Nortriptyline—HTR2C—telencephalon—epilepsy syndrome	0.000106	0.00598	CbGeAlD
Nortriptyline—HTR2A—hindbrain—epilepsy syndrome	0.000104	0.00589	CbGeAlD
Nortriptyline—HTR6—central nervous system—epilepsy syndrome	0.000104	0.00588	CbGeAlD
Nortriptyline—HTR1A—brainstem—epilepsy syndrome	0.0001	0.00567	CbGeAlD
Nortriptyline—SLC6A4—telencephalon—epilepsy syndrome	0.0001	0.00567	CbGeAlD
Nortriptyline—CHRM1—telencephalon—epilepsy syndrome	0.0001	0.00564	CbGeAlD
Nortriptyline—CHRM5—head—epilepsy syndrome	9.97e-05	0.00563	CbGeAlD
Nortriptyline—SLC6A2—brainstem—epilepsy syndrome	9.96e-05	0.00562	CbGeAlD
Nortriptyline—CHRM3—forebrain—epilepsy syndrome	9.73e-05	0.00549	CbGeAlD
Nortriptyline—HTR1A—forebrain—epilepsy syndrome	9.69e-05	0.00547	CbGeAlD
Nortriptyline—SLC6A2—forebrain—epilepsy syndrome	9.61e-05	0.00543	CbGeAlD
Nortriptyline—CYP2D6—hindbrain—epilepsy syndrome	9.51e-05	0.00537	CbGeAlD
Nortriptyline—CHRM5—nervous system—epilepsy syndrome	9.45e-05	0.00533	CbGeAlD
Nortriptyline—ADRA1A—brainstem—epilepsy syndrome	9.26e-05	0.00523	CbGeAlD
Nortriptyline—CHRM4—brain—epilepsy syndrome	9.24e-05	0.00522	CbGeAlD
Nortriptyline—ADRA1B—head—epilepsy syndrome	9.11e-05	0.00514	CbGeAlD
Nortriptyline—CHRM5—central nervous system—epilepsy syndrome	9.1e-05	0.00514	CbGeAlD
Nortriptyline—DRD2—brainstem—epilepsy syndrome	9.08e-05	0.00512	CbGeAlD
Nortriptyline—CHRM3—telencephalon—epilepsy syndrome	8.95e-05	0.00505	CbGeAlD
Nortriptyline—ADRA1A—forebrain—epilepsy syndrome	8.94e-05	0.00504	CbGeAlD
Nortriptyline—HTR1A—telencephalon—epilepsy syndrome	8.91e-05	0.00503	CbGeAlD
Nortriptyline—ADRA1D—head—epilepsy syndrome	8.91e-05	0.00503	CbGeAlD
Nortriptyline—SLC6A2—telencephalon—epilepsy syndrome	8.84e-05	0.00499	CbGeAlD
Nortriptyline—DRD2—forebrain—epilepsy syndrome	8.76e-05	0.00494	CbGeAlD
Nortriptyline—ADRA1B—nervous system—epilepsy syndrome	8.63e-05	0.00487	CbGeAlD
Nortriptyline—ADRA1D—nervous system—epilepsy syndrome	8.45e-05	0.00477	CbGeAlD
Nortriptyline—HTR2C—medulla oblongata—epilepsy syndrome	8.32e-05	0.0047	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—epilepsy syndrome	8.31e-05	0.00469	CbGeAlD
Nortriptyline—HTR6—brain—epilepsy syndrome	8.27e-05	0.00467	CbGeAlD
Nortriptyline—ORM1—spinal cord—epilepsy syndrome	8.26e-05	0.00466	CbGeAlD
Nortriptyline—ADRA1A—telencephalon—epilepsy syndrome	8.22e-05	0.00464	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—epilepsy syndrome	8.13e-05	0.00459	CbGeAlD
Nortriptyline—DRD2—telencephalon—epilepsy syndrome	8.05e-05	0.00455	CbGeAlD
Nortriptyline—HTR2C—midbrain—epilepsy syndrome	7.61e-05	0.00429	CbGeAlD
Nortriptyline—HTR2C—spinal cord—epilepsy syndrome	7.42e-05	0.00419	CbGeAlD
Nortriptyline—CHRM5—brain—epilepsy syndrome	7.22e-05	0.00408	CbGeAlD
Nortriptyline—SLC6A4—midbrain—epilepsy syndrome	7.21e-05	0.00407	CbGeAlD
Nortriptyline—SLC6A4—spinal cord—epilepsy syndrome	7.03e-05	0.00397	CbGeAlD
Nortriptyline—ORM1—nervous system—epilepsy syndrome	6.96e-05	0.00393	CbGeAlD
Nortriptyline—SLC6A2—medulla oblongata—epilepsy syndrome	6.94e-05	0.00392	CbGeAlD
Nortriptyline—HRH1—forebrain—epilepsy syndrome	6.92e-05	0.0039	CbGeAlD
Nortriptyline—CHRM2—head—epilepsy syndrome	6.84e-05	0.00386	CbGeAlD
Nortriptyline—ORM1—central nervous system—epilepsy syndrome	6.7e-05	0.00378	CbGeAlD
Nortriptyline—ADRA1B—brain—epilepsy syndrome	6.6e-05	0.00372	CbGeAlD
Nortriptyline—HTR2C—head—epilepsy syndrome	6.59e-05	0.00372	CbGeAlD
Nortriptyline—CHRM2—nervous system—epilepsy syndrome	6.49e-05	0.00366	CbGeAlD
Nortriptyline—ADRA1D—brain—epilepsy syndrome	6.46e-05	0.00364	CbGeAlD
Nortriptyline—PTGS1—forebrain—epilepsy syndrome	6.4e-05	0.00361	CbGeAlD
Nortriptyline—HTR1A—midbrain—epilepsy syndrome	6.4e-05	0.00361	CbGeAlD
Nortriptyline—HRH1—telencephalon—epilepsy syndrome	6.36e-05	0.00359	CbGeAlD
Nortriptyline—HTR2C—nervous system—epilepsy syndrome	6.25e-05	0.00353	CbGeAlD
Nortriptyline—SLC6A4—head—epilepsy syndrome	6.25e-05	0.00353	CbGeAlD
Nortriptyline—HTR1A—spinal cord—epilepsy syndrome	6.25e-05	0.00352	CbGeAlD
Nortriptyline—CHRM2—central nervous system—epilepsy syndrome	6.24e-05	0.00352	CbGeAlD
Nortriptyline—CHRM1—head—epilepsy syndrome	6.23e-05	0.00351	CbGeAlD
Nortriptyline—CYP2E1—telencephalon—epilepsy syndrome	6.11e-05	0.00345	CbGeAlD
Nortriptyline—HTR2C—central nervous system—epilepsy syndrome	6.02e-05	0.0034	CbGeAlD
Nortriptyline—HTR2A—brainstem—epilepsy syndrome	5.99e-05	0.00338	CbGeAlD
Nortriptyline—SLC6A4—nervous system—epilepsy syndrome	5.93e-05	0.00335	CbGeAlD
Nortriptyline—CHRM1—nervous system—epilepsy syndrome	5.9e-05	0.00333	CbGeAlD
Nortriptyline—PTGS1—telencephalon—epilepsy syndrome	5.89e-05	0.00332	CbGeAlD
Nortriptyline—DRD2—midbrain—epilepsy syndrome	5.78e-05	0.00326	CbGeAlD
Nortriptyline—HTR2A—forebrain—epilepsy syndrome	5.78e-05	0.00326	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—epilepsy syndrome	5.71e-05	0.00322	CbGeAlD
Nortriptyline—CHRM1—central nervous system—epilepsy syndrome	5.68e-05	0.00321	CbGeAlD
Nortriptyline—CHRM3—head—epilepsy syndrome	5.57e-05	0.00315	CbGeAlD
Nortriptyline—HTR1A—head—epilepsy syndrome	5.55e-05	0.00313	CbGeAlD
Nortriptyline—SLC6A2—head—epilepsy syndrome	5.5e-05	0.00311	CbGeAlD
Nortriptyline—CYP2D6—brainstem—epilepsy syndrome	5.45e-05	0.00308	CbGeAlD
Nortriptyline—HTR2A—telencephalon—epilepsy syndrome	5.31e-05	0.003	CbGeAlD
Nortriptyline—CHRM3—nervous system—epilepsy syndrome	5.28e-05	0.00298	CbGeAlD
Nortriptyline—CYP2D6—forebrain—epilepsy syndrome	5.26e-05	0.00297	CbGeAlD
Nortriptyline—HTR1A—nervous system—epilepsy syndrome	5.26e-05	0.00297	CbGeAlD
Nortriptyline—Imipramine—KCND2—epilepsy syndrome	5.24e-05	0.0348	CrCbGaD
Nortriptyline—SLC6A2—nervous system—epilepsy syndrome	5.22e-05	0.00295	CbGeAlD
Nortriptyline—Amitriptyline—KCND2—epilepsy syndrome	5.21e-05	0.0346	CrCbGaD
Nortriptyline—ADRA1A—head—epilepsy syndrome	5.12e-05	0.00289	CbGeAlD
Nortriptyline—CHRM3—central nervous system—epilepsy syndrome	5.09e-05	0.00287	CbGeAlD
Nortriptyline—HTR1A—central nervous system—epilepsy syndrome	5.07e-05	0.00286	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—epilepsy syndrome	5.02e-05	0.00284	CbGeAlD
Nortriptyline—DRD2—head—epilepsy syndrome	5.02e-05	0.00283	CbGeAlD
Nortriptyline—CHRM2—brain—epilepsy syndrome	4.96e-05	0.0028	CbGeAlD
Nortriptyline—HTR1A—cerebellum—epilepsy syndrome	4.95e-05	0.0028	CbGeAlD
Nortriptyline—ADRA1A—nervous system—epilepsy syndrome	4.85e-05	0.00274	CbGeAlD
Nortriptyline—Amitriptyline—KCNQ2—epilepsy syndrome	4.84e-05	0.0322	CrCbGaD
Nortriptyline—Amitriptyline—KCNQ3—epilepsy syndrome	4.84e-05	0.0322	CrCbGaD
Nortriptyline—CYP2D6—telencephalon—epilepsy syndrome	4.84e-05	0.00273	CbGeAlD
Nortriptyline—CYP2E1—medulla oblongata—epilepsy syndrome	4.8e-05	0.00271	CbGeAlD
Nortriptyline—HTR2C—brain—epilepsy syndrome	4.78e-05	0.0027	CbGeAlD
Nortriptyline—DRD2—nervous system—epilepsy syndrome	4.75e-05	0.00268	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—epilepsy syndrome	4.67e-05	0.00264	CbGeAlD
Nortriptyline—ALB—brain—epilepsy syndrome	4.66e-05	0.00263	CbGeAlD
Nortriptyline—DRD2—central nervous system—epilepsy syndrome	4.58e-05	0.00258	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—epilepsy syndrome	4.56e-05	0.00258	CbGeAlD
Nortriptyline—SLC6A4—brain—epilepsy syndrome	4.53e-05	0.00256	CbGeAlD
Nortriptyline—CHRM1—brain—epilepsy syndrome	4.51e-05	0.00255	CbGeAlD
Nortriptyline—DRD2—cerebellum—epilepsy syndrome	4.47e-05	0.00253	CbGeAlD
Nortriptyline—CYP2E1—spinal cord—epilepsy syndrome	4.28e-05	0.00242	CbGeAlD
Nortriptyline—HTR2A—medulla oblongata—epilepsy syndrome	4.17e-05	0.00236	CbGeAlD
Nortriptyline—PTGS1—spinal cord—epilepsy syndrome	4.13e-05	0.00233	CbGeAlD
Nortriptyline—Amitriptyline—NTRK2—epilepsy syndrome	4.12e-05	0.0274	CrCbGaD
Nortriptyline—CHRM3—brain—epilepsy syndrome	4.04e-05	0.00228	CbGeAlD
Nortriptyline—HTR1A—brain—epilepsy syndrome	4.02e-05	0.00227	CbGeAlD
Nortriptyline—SLC6A2—brain—epilepsy syndrome	3.99e-05	0.00225	CbGeAlD
Nortriptyline—HRH1—head—epilepsy syndrome	3.96e-05	0.00224	CbGeAlD
Nortriptyline—HTR2A—midbrain—epilepsy syndrome	3.81e-05	0.00215	CbGeAlD
Nortriptyline—CYP2E1—head—epilepsy syndrome	3.81e-05	0.00215	CbGeAlD
Nortriptyline—HRH1—nervous system—epilepsy syndrome	3.76e-05	0.00212	CbGeAlD
Nortriptyline—HTR2A—spinal cord—epilepsy syndrome	3.72e-05	0.0021	CbGeAlD
Nortriptyline—ADRA1A—brain—epilepsy syndrome	3.71e-05	0.00209	CbGeAlD
Nortriptyline—PTGS1—head—epilepsy syndrome	3.67e-05	0.00207	CbGeAlD
Nortriptyline—DRD2—brain—epilepsy syndrome	3.63e-05	0.00205	CbGeAlD
Nortriptyline—HRH1—central nervous system—epilepsy syndrome	3.62e-05	0.00204	CbGeAlD
Nortriptyline—CYP2E1—nervous system—epilepsy syndrome	3.61e-05	0.00204	CbGeAlD
Nortriptyline—PTGS1—nervous system—epilepsy syndrome	3.48e-05	0.00196	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—epilepsy syndrome	3.47e-05	0.00196	CbGeAlD
Nortriptyline—Maprotiline—CHRM3—epilepsy syndrome	3.44e-05	0.0228	CrCbGaD
Nortriptyline—CYP2E1—cerebellum—epilepsy syndrome	3.4e-05	0.00192	CbGeAlD
Nortriptyline—Dimetindene—CHRM2—epilepsy syndrome	3.39e-05	0.0225	CrCbGaD
Nortriptyline—PTGS1—central nervous system—epilepsy syndrome	3.35e-05	0.00189	CbGeAlD
Nortriptyline—HTR2A—head—epilepsy syndrome	3.31e-05	0.00187	CbGeAlD
Nortriptyline—Maprotiline—CHRM1—epilepsy syndrome	3.2e-05	0.0213	CrCbGaD
Nortriptyline—HTR2A—nervous system—epilepsy syndrome	3.14e-05	0.00177	CbGeAlD
Nortriptyline—Cyproheptadine—CHRM3—epilepsy syndrome	3.05e-05	0.0203	CrCbGaD
Nortriptyline—Epinastine—HTR7—epilepsy syndrome	3.03e-05	0.0201	CrCbGaD
Nortriptyline—HTR2A—central nervous system—epilepsy syndrome	3.02e-05	0.0017	CbGeAlD
Nortriptyline—CYP2D6—head—epilepsy syndrome	3.01e-05	0.0017	CbGeAlD
Nortriptyline—HTR2A—cerebellum—epilepsy syndrome	2.95e-05	0.00167	CbGeAlD
Nortriptyline—CYP3A4—nervous system—epilepsy syndrome	2.9e-05	0.00164	CbGeAlD
Nortriptyline—HRH1—brain—epilepsy syndrome	2.87e-05	0.00162	CbGeAlD
Nortriptyline—CYP2D6—nervous system—epilepsy syndrome	2.86e-05	0.00161	CbGeAlD
Nortriptyline—Cyproheptadine—CHRM1—epilepsy syndrome	2.84e-05	0.0189	CrCbGaD
Nortriptyline—CYP3A4—central nervous system—epilepsy syndrome	2.8e-05	0.00158	CbGeAlD
Nortriptyline—CYP2E1—brain—epilepsy syndrome	2.76e-05	0.00156	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—epilepsy syndrome	2.75e-05	0.00155	CbGeAlD
Nortriptyline—CYP2D6—cerebellum—epilepsy syndrome	2.69e-05	0.00152	CbGeAlD
Nortriptyline—Protriptyline—SLC6A4—epilepsy syndrome	2.67e-05	0.0178	CrCbGaD
Nortriptyline—PTGS1—brain—epilepsy syndrome	2.66e-05	0.0015	CbGeAlD
Nortriptyline—Maprotiline—CHRM2—epilepsy syndrome	2.62e-05	0.0174	CrCbGaD
Nortriptyline—Maprotiline—HTR7—epilepsy syndrome	2.6e-05	0.0173	CrCbGaD
Nortriptyline—Epinastine—ADRA2A—epilepsy syndrome	2.59e-05	0.0172	CrCbGaD
Nortriptyline—HTR2A—brain—epilepsy syndrome	2.4e-05	0.00135	CbGeAlD
Nortriptyline—Cyproheptadine—CHRM2—epilepsy syndrome	2.32e-05	0.0154	CrCbGaD
Nortriptyline—CYP2D6—brain—epilepsy syndrome	2.18e-05	0.00123	CbGeAlD
Nortriptyline—Chlorprothixene—CHRM3—epilepsy syndrome	2.1e-05	0.014	CrCbGaD
Nortriptyline—Chlorprothixene—CHRM1—epilepsy syndrome	1.96e-05	0.013	CrCbGaD
Nortriptyline—Protriptyline—CYP2D6—epilepsy syndrome	1.88e-05	0.0125	CrCbGaD
Nortriptyline—Doxepin—CHRM3—epilepsy syndrome	1.85e-05	0.0123	CrCbGaD
Nortriptyline—Mianserin—HTR7—epilepsy syndrome	1.75e-05	0.0116	CrCbGaD
Nortriptyline—Oxcarbazepine—CYP2C19—epilepsy syndrome	1.73e-05	0.0115	CrCbGaD
Nortriptyline—Doxepin—CHRM1—epilepsy syndrome	1.73e-05	0.0115	CrCbGaD
Nortriptyline—Desipramine—CHRM3—epilepsy syndrome	1.7e-05	0.0113	CrCbGaD
Nortriptyline—Amitriptyline—OPRD1—epilepsy syndrome	1.68e-05	0.0112	CrCbGaD
Nortriptyline—Hypersensitivity—Phenytoin—epilepsy syndrome	1.66e-05	0.000298	CcSEcCtD
Nortriptyline—Oedema—Valproic Acid—epilepsy syndrome	1.66e-05	0.000296	CcSEcCtD
Nortriptyline—Urticaria—Lamotrigine—epilepsy syndrome	1.66e-05	0.000296	CcSEcCtD
Nortriptyline—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	1.66e-05	0.000296	CcSEcCtD
Nortriptyline—Malaise—Pregabalin—epilepsy syndrome	1.65e-05	0.000296	CcSEcCtD
Nortriptyline—Nausea—Propofol—epilepsy syndrome	1.65e-05	0.000296	CcSEcCtD
Nortriptyline—Tension—Gabapentin—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Vomiting—Fosphenytoin—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Diarrhoea—Felbamate—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Body temperature increased—Lamotrigine—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Abdominal pain—Lamotrigine—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Dysgeusia—Gabapentin—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Dizziness—Diazepam—epilepsy syndrome	1.65e-05	0.000295	CcSEcCtD
Nortriptyline—Syncope—Pregabalin—epilepsy syndrome	1.65e-05	0.000294	CcSEcCtD
Nortriptyline—Leukopenia—Pregabalin—epilepsy syndrome	1.64e-05	0.000294	CcSEcCtD
Nortriptyline—Rash—Fosphenytoin—epilepsy syndrome	1.64e-05	0.000293	CcSEcCtD
Nortriptyline—Dermatitis—Fosphenytoin—epilepsy syndrome	1.64e-05	0.000292	CcSEcCtD
Nortriptyline—Nervousness—Gabapentin—epilepsy syndrome	1.63e-05	0.000292	CcSEcCtD
Nortriptyline—Asthenia—Clonazepam—epilepsy syndrome	1.63e-05	0.000292	CcSEcCtD
Nortriptyline—Headache—Fosphenytoin—epilepsy syndrome	1.63e-05	0.000291	CcSEcCtD
Nortriptyline—Hepatitis—Topiramate—epilepsy syndrome	1.63e-05	0.000291	CcSEcCtD
Nortriptyline—Thrombocytopenia—Valproic Acid—epilepsy syndrome	1.62e-05	0.00029	CcSEcCtD
Nortriptyline—Palpitations—Pregabalin—epilepsy syndrome	1.62e-05	0.00029	CcSEcCtD
Nortriptyline—Asthenia—Phenytoin—epilepsy syndrome	1.62e-05	0.00029	CcSEcCtD
Nortriptyline—Nausea—Midazolam—epilepsy syndrome	1.62e-05	0.000289	CcSEcCtD
Nortriptyline—Hallucination—Topiramate—epilepsy syndrome	1.62e-05	0.000289	CcSEcCtD
Nortriptyline—Hypoaesthesia—Topiramate—epilepsy syndrome	1.62e-05	0.000289	CcSEcCtD
Nortriptyline—Tachycardia—Valproic Acid—epilepsy syndrome	1.62e-05	0.000289	CcSEcCtD
Nortriptyline—Diarrhoea—Zonisamide—epilepsy syndrome	1.61e-05	0.000289	CcSEcCtD
Nortriptyline—Loss of consciousness—Pregabalin—epilepsy syndrome	1.61e-05	0.000288	CcSEcCtD
Nortriptyline—Asthenia—Oxcarbazepine—epilepsy syndrome	1.61e-05	0.000288	CcSEcCtD
Nortriptyline—Pruritus—Clonazepam—epilepsy syndrome	1.61e-05	0.000288	CcSEcCtD
Nortriptyline—Vomiting—Vigabatrin—epilepsy syndrome	1.61e-05	0.000288	CcSEcCtD
Nortriptyline—Oedema peripheral—Topiramate—epilepsy syndrome	1.6e-05	0.000286	CcSEcCtD
Nortriptyline—Chlorprothixene—CHRM2—epilepsy syndrome	1.6e-05	0.0106	CrCbGaD
Nortriptyline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.6e-05	0.000286	CcSEcCtD
Nortriptyline—Pruritus—Phenytoin—epilepsy syndrome	1.6e-05	0.000286	CcSEcCtD
Nortriptyline—Nausea—Levetiracetam—epilepsy syndrome	1.6e-05	0.000286	CcSEcCtD
Nortriptyline—Rash—Vigabatrin—epilepsy syndrome	1.6e-05	0.000285	CcSEcCtD
Nortriptyline—Dizziness—Felbamate—epilepsy syndrome	1.59e-05	0.000285	CcSEcCtD
Nortriptyline—Dermatitis—Vigabatrin—epilepsy syndrome	1.59e-05	0.000285	CcSEcCtD
Nortriptyline—Pruritus—Oxcarbazepine—epilepsy syndrome	1.59e-05	0.000284	CcSEcCtD
Nortriptyline—Convulsion—Pregabalin—epilepsy syndrome	1.59e-05	0.000284	CcSEcCtD
Nortriptyline—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.59e-05	0.000284	CcSEcCtD
Nortriptyline—Vision blurred—Gabapentin—epilepsy syndrome	1.59e-05	0.000284	CcSEcCtD
Nortriptyline—Headache—Vigabatrin—epilepsy syndrome	1.59e-05	0.000283	CcSEcCtD
Nortriptyline—Desipramine—CHRM1—epilepsy syndrome	1.59e-05	0.0105	CrCbGaD
Nortriptyline—Hypertension—Pregabalin—epilepsy syndrome	1.58e-05	0.000283	CcSEcCtD
Nortriptyline—Vomiting—Diazepam—epilepsy syndrome	1.58e-05	0.000283	CcSEcCtD
Nortriptyline—Anorexia—Valproic Acid—epilepsy syndrome	1.58e-05	0.000282	CcSEcCtD
Nortriptyline—Tremor—Gabapentin—epilepsy syndrome	1.58e-05	0.000282	CcSEcCtD
Nortriptyline—Rash—Diazepam—epilepsy syndrome	1.57e-05	0.000281	CcSEcCtD
Nortriptyline—Dermatitis—Diazepam—epilepsy syndrome	1.57e-05	0.000281	CcSEcCtD
Nortriptyline—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.56e-05	0.000279	CcSEcCtD
Nortriptyline—Dizziness—Zonisamide—epilepsy syndrome	1.56e-05	0.000279	CcSEcCtD
Nortriptyline—Headache—Diazepam—epilepsy syndrome	1.56e-05	0.000279	CcSEcCtD
Nortriptyline—Anxiety—Pregabalin—epilepsy syndrome	1.56e-05	0.000278	CcSEcCtD
Nortriptyline—Diarrhoea—Clonazepam—epilepsy syndrome	1.56e-05	0.000278	CcSEcCtD
Nortriptyline—Hypotension—Valproic Acid—epilepsy syndrome	1.55e-05	0.000277	CcSEcCtD
Nortriptyline—Asthenia—Carbamazepine—epilepsy syndrome	1.55e-05	0.000277	CcSEcCtD
Nortriptyline—Agitation—Gabapentin—epilepsy syndrome	1.55e-05	0.000276	CcSEcCtD
Nortriptyline—Diarrhoea—Phenytoin—epilepsy syndrome	1.55e-05	0.000276	CcSEcCtD
Nortriptyline—Discomfort—Pregabalin—epilepsy syndrome	1.54e-05	0.000276	CcSEcCtD
Nortriptyline—Nausea—Fosphenytoin—epilepsy syndrome	1.54e-05	0.000276	CcSEcCtD
Nortriptyline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.54e-05	0.000275	CcSEcCtD
Nortriptyline—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.54e-05	0.000275	CcSEcCtD
Nortriptyline—Vomiting—Felbamate—epilepsy syndrome	1.53e-05	0.000274	CcSEcCtD
Nortriptyline—Cyclobenzaprine—HTR2A—epilepsy syndrome	1.53e-05	0.0102	CrCbGaD
Nortriptyline—Dry mouth—Pregabalin—epilepsy syndrome	1.53e-05	0.000273	CcSEcCtD
Nortriptyline—Pruritus—Carbamazepine—epilepsy syndrome	1.53e-05	0.000273	CcSEcCtD
Nortriptyline—Epinastine—HTR2A—epilepsy syndrome	1.52e-05	0.0101	CrCbGaD
Nortriptyline—Rash—Felbamate—epilepsy syndrome	1.52e-05	0.000272	CcSEcCtD
Nortriptyline—Eye disorder—Topiramate—epilepsy syndrome	1.52e-05	0.000272	CcSEcCtD
Nortriptyline—Dermatitis—Felbamate—epilepsy syndrome	1.52e-05	0.000272	CcSEcCtD
Nortriptyline—Malaise—Gabapentin—epilepsy syndrome	1.52e-05	0.000271	CcSEcCtD
Nortriptyline—Tinnitus—Topiramate—epilepsy syndrome	1.52e-05	0.000271	CcSEcCtD
Nortriptyline—Headache—Felbamate—epilepsy syndrome	1.51e-05	0.00027	CcSEcCtD
Nortriptyline—Confusional state—Pregabalin—epilepsy syndrome	1.51e-05	0.00027	CcSEcCtD
Nortriptyline—Flushing—Topiramate—epilepsy syndrome	1.51e-05	0.00027	CcSEcCtD
Nortriptyline—Syncope—Gabapentin—epilepsy syndrome	1.51e-05	0.00027	CcSEcCtD
Nortriptyline—Leukopenia—Gabapentin—epilepsy syndrome	1.51e-05	0.000269	CcSEcCtD
Nortriptyline—Dizziness—Clonazepam—epilepsy syndrome	1.5e-05	0.000269	CcSEcCtD
Nortriptyline—Nausea—Vigabatrin—epilepsy syndrome	1.5e-05	0.000269	CcSEcCtD
Nortriptyline—Mianserin—ADRA2A—epilepsy syndrome	1.5e-05	0.00998	CrCbGaD
Nortriptyline—Vomiting—Zonisamide—epilepsy syndrome	1.5e-05	0.000268	CcSEcCtD
Nortriptyline—Insomnia—Valproic Acid—epilepsy syndrome	1.5e-05	0.000268	CcSEcCtD
Nortriptyline—Oedema—Pregabalin—epilepsy syndrome	1.5e-05	0.000268	CcSEcCtD
Nortriptyline—Asthenia—Lamotrigine—epilepsy syndrome	1.5e-05	0.000267	CcSEcCtD
Nortriptyline—Dizziness—Phenytoin—epilepsy syndrome	1.49e-05	0.000267	CcSEcCtD
Nortriptyline—Rash—Zonisamide—epilepsy syndrome	1.49e-05	0.000266	CcSEcCtD
Nortriptyline—Paraesthesia—Valproic Acid—epilepsy syndrome	1.49e-05	0.000266	CcSEcCtD
Nortriptyline—Palpitations—Gabapentin—epilepsy syndrome	1.49e-05	0.000266	CcSEcCtD
Nortriptyline—Dermatitis—Zonisamide—epilepsy syndrome	1.49e-05	0.000266	CcSEcCtD
Nortriptyline—Dizziness—Oxcarbazepine—epilepsy syndrome	1.49e-05	0.000266	CcSEcCtD
Nortriptyline—Nausea—Diazepam—epilepsy syndrome	1.48e-05	0.000265	CcSEcCtD
Nortriptyline—Loss of consciousness—Gabapentin—epilepsy syndrome	1.48e-05	0.000264	CcSEcCtD
Nortriptyline—Headache—Zonisamide—epilepsy syndrome	1.48e-05	0.000264	CcSEcCtD
Nortriptyline—Diarrhoea—Carbamazepine—epilepsy syndrome	1.48e-05	0.000264	CcSEcCtD
Nortriptyline—Pruritus—Lamotrigine—epilepsy syndrome	1.47e-05	0.000264	CcSEcCtD
Nortriptyline—Shock—Pregabalin—epilepsy syndrome	1.47e-05	0.000263	CcSEcCtD
Nortriptyline—Somnolence—Valproic Acid—epilepsy syndrome	1.47e-05	0.000263	CcSEcCtD
Nortriptyline—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.47e-05	0.000262	CcSEcCtD
Nortriptyline—Tachycardia—Pregabalin—epilepsy syndrome	1.46e-05	0.000261	CcSEcCtD
Nortriptyline—Dyspepsia—Valproic Acid—epilepsy syndrome	1.46e-05	0.000261	CcSEcCtD
Nortriptyline—Convulsion—Gabapentin—epilepsy syndrome	1.46e-05	0.000261	CcSEcCtD
Nortriptyline—Hypertension—Gabapentin—epilepsy syndrome	1.45e-05	0.00026	CcSEcCtD
Nortriptyline—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.45e-05	0.000259	CcSEcCtD
Nortriptyline—Vomiting—Clonazepam—epilepsy syndrome	1.45e-05	0.000259	CcSEcCtD
Nortriptyline—Imipramine—CHRM3—epilepsy syndrome	1.44e-05	0.00958	CrCbGaD
Nortriptyline—Decreased appetite—Valproic Acid—epilepsy syndrome	1.44e-05	0.000257	CcSEcCtD
Nortriptyline—Alopecia—Topiramate—epilepsy syndrome	1.44e-05	0.000257	CcSEcCtD
Nortriptyline—Vomiting—Phenytoin—epilepsy syndrome	1.44e-05	0.000257	CcSEcCtD
Nortriptyline—Rash—Clonazepam—epilepsy syndrome	1.43e-05	0.000256	CcSEcCtD
Nortriptyline—Dermatitis—Clonazepam—epilepsy syndrome	1.43e-05	0.000256	CcSEcCtD
Nortriptyline—Amitriptyline—CHRM3—epilepsy syndrome	1.43e-05	0.00952	CrCbGaD
Nortriptyline—Nausea—Felbamate—epilepsy syndrome	1.43e-05	0.000256	CcSEcCtD
Nortriptyline—Vomiting—Oxcarbazepine—epilepsy syndrome	1.43e-05	0.000256	CcSEcCtD
Nortriptyline—Fatigue—Valproic Acid—epilepsy syndrome	1.43e-05	0.000255	CcSEcCtD
Nortriptyline—Anxiety—Gabapentin—epilepsy syndrome	1.43e-05	0.000255	CcSEcCtD
Nortriptyline—Anorexia—Pregabalin—epilepsy syndrome	1.43e-05	0.000255	CcSEcCtD
Nortriptyline—Dizziness—Carbamazepine—epilepsy syndrome	1.43e-05	0.000255	CcSEcCtD
Nortriptyline—Diarrhoea—Lamotrigine—epilepsy syndrome	1.43e-05	0.000255	CcSEcCtD
Nortriptyline—Headache—Clonazepam—epilepsy syndrome	1.42e-05	0.000255	CcSEcCtD
Nortriptyline—Rash—Phenytoin—epilepsy syndrome	1.42e-05	0.000255	CcSEcCtD
Nortriptyline—Dermatitis—Phenytoin—epilepsy syndrome	1.42e-05	0.000255	CcSEcCtD
Nortriptyline—Rash—Oxcarbazepine—epilepsy syndrome	1.42e-05	0.000253	CcSEcCtD
Nortriptyline—Constipation—Valproic Acid—epilepsy syndrome	1.42e-05	0.000253	CcSEcCtD
Nortriptyline—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.42e-05	0.000253	CcSEcCtD
Nortriptyline—Headache—Phenytoin—epilepsy syndrome	1.42e-05	0.000253	CcSEcCtD
Nortriptyline—Discomfort—Gabapentin—epilepsy syndrome	1.42e-05	0.000253	CcSEcCtD
Nortriptyline—Doxepin—CHRM2—epilepsy syndrome	1.41e-05	0.00938	CrCbGaD
Nortriptyline—Headache—Oxcarbazepine—epilepsy syndrome	1.41e-05	0.000252	CcSEcCtD
Nortriptyline—Nausea—Zonisamide—epilepsy syndrome	1.4e-05	0.000251	CcSEcCtD
Nortriptyline—Cyclobenzaprine—CYP2D6—epilepsy syndrome	1.4e-05	0.00932	CrCbGaD
Nortriptyline—Dry mouth—Gabapentin—epilepsy syndrome	1.4e-05	0.00025	CcSEcCtD
Nortriptyline—Hypotension—Pregabalin—epilepsy syndrome	1.4e-05	0.00025	CcSEcCtD
Nortriptyline—Epinastine—CYP2D6—epilepsy syndrome	1.39e-05	0.00925	CrCbGaD
Nortriptyline—Tension—Topiramate—epilepsy syndrome	1.39e-05	0.000248	CcSEcCtD
Nortriptyline—Dysgeusia—Topiramate—epilepsy syndrome	1.39e-05	0.000248	CcSEcCtD
Nortriptyline—Confusional state—Gabapentin—epilepsy syndrome	1.38e-05	0.000248	CcSEcCtD
Nortriptyline—Dizziness—Lamotrigine—epilepsy syndrome	1.38e-05	0.000246	CcSEcCtD
Nortriptyline—Nervousness—Topiramate—epilepsy syndrome	1.37e-05	0.000246	CcSEcCtD
Nortriptyline—Oedema—Gabapentin—epilepsy syndrome	1.37e-05	0.000246	CcSEcCtD
Nortriptyline—Clomipramine—ADRA2A—epilepsy syndrome	1.37e-05	0.00913	CrCbGaD
Nortriptyline—Vomiting—Carbamazepine—epilepsy syndrome	1.37e-05	0.000245	CcSEcCtD
Nortriptyline—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.36e-05	0.000244	CcSEcCtD
Nortriptyline—Rash—Carbamazepine—epilepsy syndrome	1.36e-05	0.000243	CcSEcCtD
Nortriptyline—Dermatitis—Carbamazepine—epilepsy syndrome	1.36e-05	0.000243	CcSEcCtD
Nortriptyline—Insomnia—Pregabalin—epilepsy syndrome	1.35e-05	0.000242	CcSEcCtD
Nortriptyline—Nausea—Clonazepam—epilepsy syndrome	1.35e-05	0.000242	CcSEcCtD
Nortriptyline—Headache—Carbamazepine—epilepsy syndrome	1.35e-05	0.000242	CcSEcCtD
Nortriptyline—Shock—Gabapentin—epilepsy syndrome	1.35e-05	0.000242	CcSEcCtD
Nortriptyline—Paraesthesia—Pregabalin—epilepsy syndrome	1.34e-05	0.00024	CcSEcCtD
Nortriptyline—Imipramine—CHRM1—epilepsy syndrome	1.34e-05	0.00894	CrCbGaD
Nortriptyline—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.34e-05	0.00024	CcSEcCtD
Nortriptyline—Nausea—Phenytoin—epilepsy syndrome	1.34e-05	0.00024	CcSEcCtD
Nortriptyline—Protriptyline—ABCB1—epilepsy syndrome	1.34e-05	0.00891	CrCbGaD
Nortriptyline—Tachycardia—Gabapentin—epilepsy syndrome	1.34e-05	0.00024	CcSEcCtD
Nortriptyline—Amitriptyline—CHRM1—epilepsy syndrome	1.34e-05	0.00888	CrCbGaD
Nortriptyline—Nausea—Oxcarbazepine—epilepsy syndrome	1.33e-05	0.000239	CcSEcCtD
Nortriptyline—Vision blurred—Topiramate—epilepsy syndrome	1.33e-05	0.000239	CcSEcCtD
Nortriptyline—Somnolence—Pregabalin—epilepsy syndrome	1.33e-05	0.000238	CcSEcCtD
Nortriptyline—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.33e-05	0.000237	CcSEcCtD
Nortriptyline—Tremor—Topiramate—epilepsy syndrome	1.33e-05	0.000237	CcSEcCtD
Nortriptyline—Vomiting—Lamotrigine—epilepsy syndrome	1.33e-05	0.000237	CcSEcCtD
Nortriptyline—Urticaria—Valproic Acid—epilepsy syndrome	1.32e-05	0.000235	CcSEcCtD
Nortriptyline—Rash—Lamotrigine—epilepsy syndrome	1.31e-05	0.000235	CcSEcCtD
Nortriptyline—Ill-defined disorder—Topiramate—epilepsy syndrome	1.31e-05	0.000235	CcSEcCtD
Nortriptyline—Dermatitis—Lamotrigine—epilepsy syndrome	1.31e-05	0.000235	CcSEcCtD
Nortriptyline—Maprotiline—HTR2A—epilepsy syndrome	1.31e-05	0.00871	CrCbGaD
Nortriptyline—Abdominal pain—Valproic Acid—epilepsy syndrome	1.31e-05	0.000234	CcSEcCtD
Nortriptyline—Body temperature increased—Valproic Acid—epilepsy syndrome	1.31e-05	0.000234	CcSEcCtD
Nortriptyline—Anorexia—Gabapentin—epilepsy syndrome	1.31e-05	0.000234	CcSEcCtD
Nortriptyline—Headache—Lamotrigine—epilepsy syndrome	1.31e-05	0.000234	CcSEcCtD
Nortriptyline—Decreased appetite—Pregabalin—epilepsy syndrome	1.3e-05	0.000233	CcSEcCtD
Nortriptyline—Agitation—Topiramate—epilepsy syndrome	1.3e-05	0.000233	CcSEcCtD
Nortriptyline—Desipramine—CHRM2—epilepsy syndrome	1.29e-05	0.0086	CrCbGaD
Nortriptyline—Fatigue—Pregabalin—epilepsy syndrome	1.29e-05	0.000231	CcSEcCtD
Nortriptyline—Amitriptyline—OPRM1—epilepsy syndrome	1.29e-05	0.00857	CrCbGaD
Nortriptyline—Hypotension—Gabapentin—epilepsy syndrome	1.28e-05	0.000229	CcSEcCtD
Nortriptyline—Nausea—Carbamazepine—epilepsy syndrome	1.28e-05	0.000229	CcSEcCtD
Nortriptyline—Constipation—Pregabalin—epilepsy syndrome	1.28e-05	0.000229	CcSEcCtD
Nortriptyline—Malaise—Topiramate—epilepsy syndrome	1.28e-05	0.000228	CcSEcCtD
Nortriptyline—Syncope—Topiramate—epilepsy syndrome	1.27e-05	0.000227	CcSEcCtD
Nortriptyline—Leukopenia—Topiramate—epilepsy syndrome	1.27e-05	0.000227	CcSEcCtD
Nortriptyline—Trimipramine—ADRA2A—epilepsy syndrome	1.26e-05	0.0084	CrCbGaD
Nortriptyline—Palpitations—Topiramate—epilepsy syndrome	1.25e-05	0.000224	CcSEcCtD
Nortriptyline—Loss of consciousness—Topiramate—epilepsy syndrome	1.24e-05	0.000222	CcSEcCtD
Nortriptyline—Insomnia—Gabapentin—epilepsy syndrome	1.24e-05	0.000222	CcSEcCtD
Nortriptyline—Nausea—Lamotrigine—epilepsy syndrome	1.24e-05	0.000221	CcSEcCtD
Nortriptyline—Feeling abnormal—Pregabalin—epilepsy syndrome	1.23e-05	0.000221	CcSEcCtD
Nortriptyline—Paraesthesia—Gabapentin—epilepsy syndrome	1.23e-05	0.00022	CcSEcCtD
Nortriptyline—Convulsion—Topiramate—epilepsy syndrome	1.23e-05	0.000219	CcSEcCtD
Nortriptyline—Hypertension—Topiramate—epilepsy syndrome	1.22e-05	0.000219	CcSEcCtD
Nortriptyline—Somnolence—Gabapentin—epilepsy syndrome	1.22e-05	0.000218	CcSEcCtD
Nortriptyline—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.22e-05	0.000218	CcSEcCtD
Nortriptyline—Dyspepsia—Gabapentin—epilepsy syndrome	1.21e-05	0.000216	CcSEcCtD
Nortriptyline—Doxepin—ADRA2A—epilepsy syndrome	1.2e-05	0.008	CrCbGaD
Nortriptyline—Anxiety—Topiramate—epilepsy syndrome	1.2e-05	0.000215	CcSEcCtD
Nortriptyline—Maprotiline—CYP2D6—epilepsy syndrome	1.2e-05	0.00796	CrCbGaD
Nortriptyline—Decreased appetite—Gabapentin—epilepsy syndrome	1.19e-05	0.000213	CcSEcCtD
Nortriptyline—Discomfort—Topiramate—epilepsy syndrome	1.19e-05	0.000213	CcSEcCtD
Nortriptyline—Urticaria—Pregabalin—epilepsy syndrome	1.19e-05	0.000213	CcSEcCtD
Nortriptyline—Asthenia—Valproic Acid—epilepsy syndrome	1.19e-05	0.000213	CcSEcCtD
Nortriptyline—Fatigue—Gabapentin—epilepsy syndrome	1.18e-05	0.000212	CcSEcCtD
Nortriptyline—Abdominal pain—Pregabalin—epilepsy syndrome	1.18e-05	0.000212	CcSEcCtD
Nortriptyline—Body temperature increased—Pregabalin—epilepsy syndrome	1.18e-05	0.000212	CcSEcCtD
Nortriptyline—Dry mouth—Topiramate—epilepsy syndrome	1.18e-05	0.000211	CcSEcCtD
Nortriptyline—Constipation—Gabapentin—epilepsy syndrome	1.17e-05	0.00021	CcSEcCtD
Nortriptyline—Pruritus—Valproic Acid—epilepsy syndrome	1.17e-05	0.00021	CcSEcCtD
Nortriptyline—Atomoxetine—SLC6A4—epilepsy syndrome	1.17e-05	0.00779	CrCbGaD
Nortriptyline—Confusional state—Topiramate—epilepsy syndrome	1.16e-05	0.000208	CcSEcCtD
Nortriptyline—Cyproheptadine—HTR2A—epilepsy syndrome	1.16e-05	0.00772	CrCbGaD
Nortriptyline—Oedema—Topiramate—epilepsy syndrome	1.16e-05	0.000207	CcSEcCtD
Nortriptyline—Mianserin—SLC6A4—epilepsy syndrome	1.15e-05	0.00761	CrCbGaD
Nortriptyline—Shock—Topiramate—epilepsy syndrome	1.14e-05	0.000203	CcSEcCtD
Nortriptyline—Diarrhoea—Valproic Acid—epilepsy syndrome	1.13e-05	0.000203	CcSEcCtD
Nortriptyline—Feeling abnormal—Gabapentin—epilepsy syndrome	1.13e-05	0.000202	CcSEcCtD
Nortriptyline—Thrombocytopenia—Topiramate—epilepsy syndrome	1.13e-05	0.000202	CcSEcCtD
Nortriptyline—Tachycardia—Topiramate—epilepsy syndrome	1.13e-05	0.000202	CcSEcCtD
Nortriptyline—Hyperhidrosis—Topiramate—epilepsy syndrome	1.12e-05	0.0002	CcSEcCtD
Nortriptyline—Atomoxetine—CYP2C19—epilepsy syndrome	1.11e-05	0.00738	CrCbGaD
Nortriptyline—Hypersensitivity—Pregabalin—epilepsy syndrome	1.1e-05	0.000197	CcSEcCtD
Nortriptyline—Anorexia—Topiramate—epilepsy syndrome	1.1e-05	0.000197	CcSEcCtD
Nortriptyline—Imipramine—CHRM2—epilepsy syndrome	1.1e-05	0.0073	CrCbGaD
Nortriptyline—Dizziness—Valproic Acid—epilepsy syndrome	1.1e-05	0.000196	CcSEcCtD
Nortriptyline—Imipramine—HTR7—epilepsy syndrome	1.09e-05	0.00726	CrCbGaD
Nortriptyline—Amitriptyline—CHRM2—epilepsy syndrome	1.09e-05	0.00725	CrCbGaD
Nortriptyline—Urticaria—Gabapentin—epilepsy syndrome	1.09e-05	0.000195	CcSEcCtD
Nortriptyline—Amitriptyline—HTR7—epilepsy syndrome	1.09e-05	0.00722	CrCbGaD
Nortriptyline—Body temperature increased—Gabapentin—epilepsy syndrome	1.09e-05	0.000194	CcSEcCtD
Nortriptyline—Abdominal pain—Gabapentin—epilepsy syndrome	1.09e-05	0.000194	CcSEcCtD
Nortriptyline—Hypotension—Topiramate—epilepsy syndrome	1.08e-05	0.000193	CcSEcCtD
Nortriptyline—Asthenia—Pregabalin—epilepsy syndrome	1.07e-05	0.000192	CcSEcCtD
Nortriptyline—Pruritus—Pregabalin—epilepsy syndrome	1.06e-05	0.000189	CcSEcCtD
Nortriptyline—Vomiting—Valproic Acid—epilepsy syndrome	1.05e-05	0.000188	CcSEcCtD
Nortriptyline—Clomipramine—SLC6A4—epilepsy syndrome	1.05e-05	0.00696	CrCbGaD
Nortriptyline—Insomnia—Topiramate—epilepsy syndrome	1.04e-05	0.000187	CcSEcCtD
Nortriptyline—Rash—Valproic Acid—epilepsy syndrome	1.04e-05	0.000187	CcSEcCtD
Nortriptyline—Dermatitis—Valproic Acid—epilepsy syndrome	1.04e-05	0.000187	CcSEcCtD
Nortriptyline—Headache—Valproic Acid—epilepsy syndrome	1.04e-05	0.000186	CcSEcCtD
Nortriptyline—Paraesthesia—Topiramate—epilepsy syndrome	1.04e-05	0.000185	CcSEcCtD
Nortriptyline—Somnolence—Topiramate—epilepsy syndrome	1.03e-05	0.000184	CcSEcCtD
Nortriptyline—Diarrhoea—Pregabalin—epilepsy syndrome	1.02e-05	0.000183	CcSEcCtD
Nortriptyline—Dyspepsia—Topiramate—epilepsy syndrome	1.02e-05	0.000182	CcSEcCtD
Nortriptyline—Hypersensitivity—Gabapentin—epilepsy syndrome	1.01e-05	0.000181	CcSEcCtD
Nortriptyline—Decreased appetite—Topiramate—epilepsy syndrome	1e-05	0.00018	CcSEcCtD
Nortriptyline—Fatigue—Topiramate—epilepsy syndrome	9.96e-06	0.000178	CcSEcCtD
Nortriptyline—Epinastine—ABCB1—epilepsy syndrome	9.93e-06	0.0066	CrCbGaD
Nortriptyline—Clomipramine—CYP2C19—epilepsy syndrome	9.93e-06	0.0066	CrCbGaD
Nortriptyline—Dizziness—Pregabalin—epilepsy syndrome	9.9e-06	0.000177	CcSEcCtD
Nortriptyline—Constipation—Topiramate—epilepsy syndrome	9.88e-06	0.000177	CcSEcCtD
Nortriptyline—Asthenia—Gabapentin—epilepsy syndrome	9.85e-06	0.000176	CcSEcCtD
Nortriptyline—Nausea—Valproic Acid—epilepsy syndrome	9.84e-06	0.000176	CcSEcCtD
Nortriptyline—Pruritus—Gabapentin—epilepsy syndrome	9.71e-06	0.000174	CcSEcCtD
Nortriptyline—Trimipramine—SLC6A4—epilepsy syndrome	9.64e-06	0.00641	CrCbGaD
Nortriptyline—Oxcarbazepine—ALB—epilepsy syndrome	9.59e-06	0.00638	CrCbGaD
Nortriptyline—Vomiting—Pregabalin—epilepsy syndrome	9.52e-06	0.00017	CcSEcCtD
Nortriptyline—Feeling abnormal—Topiramate—epilepsy syndrome	9.52e-06	0.00017	CcSEcCtD
Nortriptyline—Rash—Pregabalin—epilepsy syndrome	9.44e-06	0.000169	CcSEcCtD
Nortriptyline—Dermatitis—Pregabalin—epilepsy syndrome	9.43e-06	0.000169	CcSEcCtD
Nortriptyline—Diarrhoea—Gabapentin—epilepsy syndrome	9.39e-06	0.000168	CcSEcCtD
Nortriptyline—Headache—Pregabalin—epilepsy syndrome	9.38e-06	0.000168	CcSEcCtD
Nortriptyline—Amitriptyline—ADRA2A—epilepsy syndrome	9.31e-06	0.00619	CrCbGaD
Nortriptyline—Doxepin—SLC6A4—epilepsy syndrome	9.18e-06	0.00611	CrCbGaD
Nortriptyline—Urticaria—Topiramate—epilepsy syndrome	9.18e-06	0.000164	CcSEcCtD
Nortriptyline—Trimipramine—CYP2C19—epilepsy syndrome	9.13e-06	0.00607	CrCbGaD
Nortriptyline—Body temperature increased—Topiramate—epilepsy syndrome	9.13e-06	0.000163	CcSEcCtD
Nortriptyline—Abdominal pain—Topiramate—epilepsy syndrome	9.13e-06	0.000163	CcSEcCtD
Nortriptyline—Dizziness—Gabapentin—epilepsy syndrome	9.08e-06	0.000162	CcSEcCtD
Nortriptyline—Atomoxetine—HTR2A—epilepsy syndrome	9e-06	0.00599	CrCbGaD
Nortriptyline—Nausea—Pregabalin—epilepsy syndrome	8.89e-06	0.000159	CcSEcCtD
Nortriptyline—Mianserin—HTR2A—epilepsy syndrome	8.8e-06	0.00585	CrCbGaD
Nortriptyline—Vomiting—Gabapentin—epilepsy syndrome	8.73e-06	0.000156	CcSEcCtD
Nortriptyline—Doxepin—CYP2C19—epilepsy syndrome	8.71e-06	0.00579	CrCbGaD
Nortriptyline—Rash—Gabapentin—epilepsy syndrome	8.66e-06	0.000155	CcSEcCtD
Nortriptyline—Dermatitis—Gabapentin—epilepsy syndrome	8.65e-06	0.000155	CcSEcCtD
Nortriptyline—Headache—Gabapentin—epilepsy syndrome	8.6e-06	0.000154	CcSEcCtD
Nortriptyline—Maprotiline—ABCB1—epilepsy syndrome	8.55e-06	0.00568	CrCbGaD
Nortriptyline—Hypersensitivity—Topiramate—epilepsy syndrome	8.51e-06	0.000152	CcSEcCtD
Nortriptyline—Desipramine—SLC6A4—epilepsy syndrome	8.43e-06	0.0056	CrCbGaD
Nortriptyline—Asthenia—Topiramate—epilepsy syndrome	8.29e-06	0.000148	CcSEcCtD
Nortriptyline—Atomoxetine—CYP2D6—epilepsy syndrome	8.23e-06	0.00547	CrCbGaD
Nortriptyline—Pruritus—Topiramate—epilepsy syndrome	8.17e-06	0.000146	CcSEcCtD
Nortriptyline—Nausea—Gabapentin—epilepsy syndrome	8.16e-06	0.000146	CcSEcCtD
Nortriptyline—Clomipramine—HTR2A—epilepsy syndrome	8.05e-06	0.00535	CrCbGaD
Nortriptyline—Mianserin—CYP2D6—epilepsy syndrome	8.05e-06	0.00535	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—epilepsy syndrome	8.01e-06	0.00533	CrCbGaD
Nortriptyline—Desipramine—CYP2C19—epilepsy syndrome	7.99e-06	0.00531	CrCbGaD
Nortriptyline—Diarrhoea—Topiramate—epilepsy syndrome	7.9e-06	0.000141	CcSEcCtD
Nortriptyline—Dizziness—Topiramate—epilepsy syndrome	7.64e-06	0.000137	CcSEcCtD
Nortriptyline—Trimipramine—HTR2A—epilepsy syndrome	7.41e-06	0.00492	CrCbGaD
Nortriptyline—Clomipramine—CYP2D6—epilepsy syndrome	7.36e-06	0.00489	CrCbGaD
Nortriptyline—Vomiting—Topiramate—epilepsy syndrome	7.34e-06	0.000131	CcSEcCtD
Nortriptyline—Rash—Topiramate—epilepsy syndrome	7.28e-06	0.00013	CcSEcCtD
Nortriptyline—Dermatitis—Topiramate—epilepsy syndrome	7.28e-06	0.00013	CcSEcCtD
Nortriptyline—Headache—Topiramate—epilepsy syndrome	7.24e-06	0.000129	CcSEcCtD
Nortriptyline—Imipramine—SLC6A4—epilepsy syndrome	7.15e-06	0.00475	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—epilepsy syndrome	7.1e-06	0.00472	CrCbGaD
Nortriptyline—Doxepin—HTR2A—epilepsy syndrome	7.06e-06	0.00469	CrCbGaD
Nortriptyline—Nausea—Topiramate—epilepsy syndrome	6.86e-06	0.000123	CcSEcCtD
Nortriptyline—Imipramine—CYP2C19—epilepsy syndrome	6.77e-06	0.0045	CrCbGaD
Nortriptyline—Trimipramine—CYP2D6—epilepsy syndrome	6.77e-06	0.0045	CrCbGaD
Nortriptyline—Amitriptyline—CYP2C19—epilepsy syndrome	6.73e-06	0.00448	CrCbGaD
Nortriptyline—Desipramine—HTR2A—epilepsy syndrome	6.48e-06	0.00431	CrCbGaD
Nortriptyline—Doxepin—CYP2D6—epilepsy syndrome	6.45e-06	0.00429	CrCbGaD
Nortriptyline—Desipramine—CYP2D6—epilepsy syndrome	5.92e-06	0.00394	CrCbGaD
Nortriptyline—Clomipramine—ALB—epilepsy syndrome	5.51e-06	0.00366	CrCbGaD
Nortriptyline—Imipramine—HTR2A—epilepsy syndrome	5.49e-06	0.00365	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—epilepsy syndrome	5.46e-06	0.00363	CrCbGaD
Nortriptyline—Clomipramine—ABCB1—epilepsy syndrome	5.26e-06	0.00349	CrCbGaD
Nortriptyline—Chlorprothixene—ABCB1—epilepsy syndrome	5.23e-06	0.00348	CrCbGaD
Nortriptyline—Imipramine—CYP2D6—epilepsy syndrome	5.02e-06	0.00334	CrCbGaD
Nortriptyline—Amitriptyline—CYP2D6—epilepsy syndrome	4.99e-06	0.00332	CrCbGaD
Nortriptyline—Trimipramine—ABCB1—epilepsy syndrome	4.84e-06	0.00322	CrCbGaD
Nortriptyline—Doxepin—ABCB1—epilepsy syndrome	4.61e-06	0.00306	CrCbGaD
Nortriptyline—Desipramine—ABCB1—epilepsy syndrome	4.23e-06	0.00281	CrCbGaD
Nortriptyline—Amitriptyline—ALB—epilepsy syndrome	3.73e-06	0.00248	CrCbGaD
Nortriptyline—Imipramine—ABCB1—epilepsy syndrome	3.59e-06	0.00238	CrCbGaD
Nortriptyline—Amitriptyline—ABCB1—epilepsy syndrome	3.56e-06	0.00237	CrCbGaD
Nortriptyline—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	4.5e-07	1.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	4.48e-07	1.29e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.47e-07	1.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	4.45e-07	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	4.45e-07	1.28e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.43e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.42e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	4.42e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	4.41e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.41e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TH—epilepsy syndrome	4.41e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	4.41e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.41e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	4.4e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	4.4e-07	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	4.39e-07	1.26e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.39e-07	1.26e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	4.37e-07	1.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.37e-07	1.26e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—epilepsy syndrome	4.36e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	4.35e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	4.35e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	4.34e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.34e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	4.34e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	4.33e-07	1.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	4.32e-07	1.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	4.31e-07	1.24e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.31e-07	1.24e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.3e-07	1.24e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAT—epilepsy syndrome	4.29e-07	1.23e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	4.28e-07	1.23e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	4.28e-07	1.23e-05	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	4.26e-07	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.26e-07	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.25e-07	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.23e-07	1.22e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	4.22e-07	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GPX1—epilepsy syndrome	4.21e-07	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	4.17e-07	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	4.16e-07	1.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.13e-07	1.19e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	4.13e-07	1.19e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AGT—epilepsy syndrome	4.12e-07	1.18e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	4.11e-07	1.18e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—POMC—epilepsy syndrome	4.1e-07	1.18e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	4.1e-07	1.18e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—SRC—epilepsy syndrome	4.07e-07	1.17e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	4.04e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.03e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—epilepsy syndrome	4.03e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—POMC—epilepsy syndrome	4.03e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—POMC—epilepsy syndrome	4.03e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—POMC—epilepsy syndrome	4.02e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.01e-07	1.15e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.01e-07	1.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	4e-07	1.15e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4e-07	1.15e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	3.99e-07	1.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	3.97e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	3.96e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.96e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.95e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	3.95e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.94e-07	1.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	3.93e-07	1.13e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.93e-07	1.13e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.91e-07	1.13e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.88e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.88e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	3.87e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.87e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	3.85e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.84e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.84e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	3.83e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.82e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.82e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	3.81e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	3.76e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	3.75e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.74e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.69e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.68e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.68e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—epilepsy syndrome	3.68e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—epilepsy syndrome	3.67e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.65e-07	1.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.64e-07	1.05e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.63e-07	1.05e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.63e-07	1.04e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	3.63e-07	1.04e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.62e-07	1.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.62e-07	1.04e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.58e-07	1.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.58e-07	1.03e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.57e-07	1.03e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.56e-07	1.02e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.55e-07	1.02e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.54e-07	1.02e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.53e-07	1.02e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.5e-07	1.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.49e-07	1e-05	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.49e-07	1e-05	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.47e-07	9.99e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—POMC—epilepsy syndrome	3.46e-07	9.97e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	3.46e-07	9.95e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.46e-07	9.94e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.45e-07	9.93e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.44e-07	9.9e-06	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—epilepsy syndrome	3.43e-07	9.85e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.41e-07	9.82e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TH—epilepsy syndrome	3.4e-07	9.79e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.4e-07	9.78e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.37e-07	9.69e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.37e-07	9.69e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—RELA—epilepsy syndrome	3.37e-07	9.68e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	3.36e-07	9.66e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	3.34e-07	9.61e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.33e-07	9.58e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.32e-07	9.56e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.31e-07	9.53e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.3e-07	9.51e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.3e-07	9.5e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.3e-07	9.5e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.29e-07	9.48e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.29e-07	9.47e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.28e-07	9.45e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.28e-07	9.44e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	3.27e-07	9.4e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.25e-07	9.35e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.25e-07	9.35e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.25e-07	9.34e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.24e-07	9.33e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.24e-07	9.32e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.23e-07	9.29e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.22e-07	9.26e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	3.22e-07	9.25e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	3.21e-07	9.23e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.2e-07	9.2e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.19e-07	9.17e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.18e-07	9.15e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.17e-07	9.12e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.15e-07	9.07e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	3.11e-07	8.95e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—epilepsy syndrome	3.11e-07	8.95e-06	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.06e-07	8.81e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.04e-07	8.73e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.02e-07	8.68e-06	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.01e-07	8.67e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.01e-07	8.67e-06	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.01e-07	8.65e-06	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3e-07	8.63e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3e-07	8.62e-06	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.99e-07	8.6e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.99e-07	8.59e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.98e-07	8.57e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.97e-07	8.55e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.96e-07	8.52e-06	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.96e-07	8.52e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.95e-07	8.49e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.95e-07	8.48e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.93e-07	8.44e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.93e-07	8.44e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.92e-07	8.41e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.92e-07	8.4e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.9e-07	8.35e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.9e-07	8.33e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.89e-07	8.3e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.88e-07	8.28e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.88e-07	8.28e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.87e-07	8.25e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.87e-07	8.25e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.86e-07	8.23e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.85e-07	8.2e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.84e-07	8.17e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.84e-07	8.17e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.84e-07	8.16e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.84e-07	8.16e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.82e-07	8.12e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.82e-07	8.11e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.82e-07	8.1e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.81e-07	8.08e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.8e-07	8.06e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.8e-07	8.05e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.79e-07	8.04e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.78e-07	8e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.77e-07	7.97e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.76e-07	7.95e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—epilepsy syndrome	2.76e-07	7.95e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.74e-07	7.88e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.73e-07	7.86e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.73e-07	7.84e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.72e-07	7.83e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.71e-07	7.81e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.69e-07	7.73e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.68e-07	7.71e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	7.61e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.61e-07	7.5e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.6e-07	7.49e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.6e-07	7.47e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.59e-07	7.45e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.59e-07	7.44e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.58e-07	7.42e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.58e-07	7.41e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.56e-07	7.35e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.55e-07	7.33e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.53e-07	7.29e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.53e-07	7.29e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.53e-07	7.28e-06	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	2.53e-07	7.28e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.52e-07	7.25e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.51e-07	7.23e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.49e-07	7.16e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.48e-07	7.14e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.48e-07	7.14e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.42e-07	6.97e-06	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-07	6.86e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.28e-07	6.57e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.28e-07	6.56e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.26e-07	6.51e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.22e-07	6.39e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.21e-07	6.36e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.18e-07	6.26e-06	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.16e-07	6.22e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	2.15e-07	6.18e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.93e-07	5.56e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.92e-07	5.52e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.87e-07	5.39e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.87e-07	5.38e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.86e-07	5.36e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.78e-07	5.13e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.71e-07	4.9e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.64e-07	4.73e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.62e-07	4.65e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—epilepsy syndrome	1.62e-07	4.65e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	4.64e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.61e-07	4.64e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	4.63e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.6e-07	4.61e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.59e-07	4.57e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-07	4.56e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.49e-07	4.29e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—epilepsy syndrome	1.39e-07	4e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.25e-07	3.59e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.15e-07	3.3e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.14e-07	3.27e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—epilepsy syndrome	9.71e-08	2.79e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.5e-08	2.16e-06	CbGpPWpGaD
